The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

ESMO GI 2020

1 - 4 Jul 2020

The International Convention Center of Barcelona, Barcelona, Spain

CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as fi...

Prof Bruno Sangro - University of Navarra, Pamplona, Spain

CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC ( Prof Bruno Sangro - University of Navarra, Pamplona, Spain )

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patie...

Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy ( Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India )

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal aden...

Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma ( Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA )

More from ecancer